SCHEMBL17703198

SCHEMBL17703198

CC1(C)c2ccc(-c3ccc4c(c3)c3cc(C#N)ccc3n4-c3ccccc3)cc2Oc2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 7/20 0.36
▸ ALDH1A3 P47895 1/20 0.33
▸ MYC P01106 1/20 0.33
▸ MEN1 O00255 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ CLK4 Q9HAZ1 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PIK3CD O00329 2/20 0.32
▸ PIK3CA P42336 2/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ PRKD3 O94806 1/20 0.32
▸ ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17703197 0.97 ABCG2 (0.34) ABCG2ALDH1A3MYCMEN1KMT2A
SCHEMBL17704024 0.94 ABCG2 (0.36) ABCG2ALDH1A3MYCMEN1KMT2A
SCHEMBL17703194 0.94 CYP1A2 (0.36) ABCG2MEN1KMT2AALDH1A1CLK4
SCHEMBL17703195 0.93 MYC (0.41) ABCG2ALDH1A3MYCKMT2AALDH1A1
SCHEMBL17703204 0.92 ALDH1A3 (0.35) ALDH1A3MYCALDH1A1CLK4CYP1A2
SCHEMBL17704022 0.91 ABCC9 (0.35) ABCG2ALDH1A3MYCMEN1KMT2A
SCHEMBL17703991 0.88 CYP1A2 (0.36) ABCG2ALDH1A3MEN1KMT2AALDH1A1
SCHEMBL17703219 0.88 ABCG2 (0.34) ABCG2ALDH1A3MYCMEN1KMT2A
SCHEMBL17703190 0.87 ABCC9 (0.32) PIK3CDPIK3CAABCB1PGRABCC9
SCHEMBL17704023 0.86 MYC (0.41) ABCG2ALDH1A3MYCKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9722187-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 — — US disclosed
US-9722187-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 — — US disclosed
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, AOX1, CYP1A1 ABCG2 3300/4885ALDH1A3 60/4885MYC 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback